Live Breaking News & Updates on Astrazeneca coronavirus vaccine

Stay informed with the latest breaking news from Astrazeneca coronavirus vaccine on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Astrazeneca coronavirus vaccine and stay connected to the pulse of your community

Breakfast-20201230-07:16:00

need to develop this. you've talked about the race now between getting the vaccine rolled out and into people's arms, and the spread of this new strain of the vaccine, which seems to be particularly contagious. today the tier ofs are going to be reviewed. what is your view on the way that things need to move now in order to achieve keeping a lid on things as best as possible? i think we are really facing a very stark choice between many tens of thousands of avoidable deaths, despite of the vaccine, or tighter restrictions across the country that will damage our economy. i think the scale of the thread that we face means that we really do need to tighten across the country. i would expect that to be the decision today. we could see a lockdown. different parts of the uk have different rules. this primarily will be about england. do you expect a full lockdown? i think a tear for is

Astrazeneca-coronavirus-vaccine , People , Need , Strain , Race , Arms , Ofs , Spread , Things , Way , Order , Choice

Breakfast-20201230-07:06:00

hancock at half past seven. so many questions for him about all of that. we know, of course, both these new strain. what can you tell us about this vaccine and of the new strain? so, this vaccine should be effective against the new variant of coronavirus. there is lab work being done that is checking those. it has a broad range against the protein which sits on the surface of coronavirus. and although there are changes in this variant, which make it more contagious, the vaccine, and also the pfizer vaccines, should be effective. if, at any point, there are further variations, it can be tweaked reasonably quickly. there is no suggestion, but the assumption would be this vaccine should be effective. also, i would imagine a lot of people are watching this morning. those who want the vaccine will say, when can i get it? do

Astrazeneca-coronavirus-vaccine , Al-l , Questions , Strain , Course , Half , Seven , Corona-virus , Variant , Lab-work , Protein , Range

Breakfast-20201230-07:07:00

people need to wait? yeah, people need to wait. a lot of the over 80s have been done now. but it is going to be done fairly strictly in terms of age ranges. so the 80 plus front line health care workers, then the 75 plus. then the 70 plus, going down like that. extremely clinically vulnerable people are high on the list. then it will be people who have underlying health conditions, about 8 million people there who are going to be called in the coming months. but yeah, people should wait, they should be patient. we are very, very close here. what it is a race between the vaccine and of the virus, with this contagious new version, this new variant of coronavirus. so version, this new variant of coronavirus. so we version, this new variant of coronavirus. so we have to try to hold on. one of the really interesting things is that the

People , Lot , Terms , Front-line , Over-80s , Age-range , 80 , Health-care-workers , List , 70 , 75 , Astrazeneca-coronavirus-vaccine

Breakfast-20201230-07:11:00

in the past few minutes, the oxford/astrazeneca coronavirus vaccine has been approved for use in the uk by the regulator, the mhra. the government has ordered 100 million doses of the vaccine which means that immunisation can be dramatically speeded up across the uk. we can speak now to professor andrew hayward, who is a member of sage and a professor of infectious disease epidemiology at university college london. good morning. thank you so much work talking to us. fair to call this a game changer? it is a game changer. imean, game changer? it is a game changer. i mean, it's exactly what we need right now. we're facing an extraordinarily difficult situation with the step change in the transmissibility of the virus, which means we need a step change in our response. i think essentially what this has turned this into is a race between us and the virus, and we need to slow the virus down as much as we can wisely get as many people as we can wisely get as many people

Astrazeneca-coronavirus-vaccine , Government , Uk , Use , Doses , Immunisation , Oxford , Medicines-regulator , 100-million , Us , Work , Professor-hayward

Breakfast-20201230-07:32:00

the next few days, it continues to be cold, very cold for the time of year, with the risk of the odd light shower. that's it. plenty more on our website at the usual address. now it's back to roger and louise hello, this is breakfast with rogerjohnson and louise minchin. good morning. the big news this morning the approval by the medicines regulator of the oxford university astrazeneca coronavirus vaccine which has been approved for use in the uk. that happened at 7am and it has been described by fergus walsh is a game changer and lots more information to come on this and so many questions to be answered but let's tell you what we know so far. there has been a department of health and social care quote from a spokesperson saying that from today the nhs across the uk will prioritise giving the first dose of the vaccine to those in the most

Risk , Cold , Roger , Odd-light-shower , Address , Website , Louise-hello , Breakfast , News , Louise-minchin , Oxford , Roger-johnson

Breakfast-20201230-07:21:00

or put me at risk. but when i read the information i felt that the risk was small. of course there was a risk. it was an untested experimental vaccine. but i felt as though i could trust the research team and the nhs, because whenever i've needed the nhs in the past they've always been there for me. so i felt i could trust them. lydia, without people like you it would not have been approved, or it would not have been approved, or it would not have been approved, or it would not have been able to go through the process. thank you very much indeed. let's talk to rachel reeves, the shadow cabinet minister. good morning. thank you for talking to us. you originally agreed kindly to talk about brexit later on over the trade deal. we will get onto that. first of all, your reaction to the news this morning that the oxford astrazeneca vaccine has been approved ? that the oxford astrazeneca vaccine has been approved? well, isjust

Astrazeneca-coronavirus-vaccine , Risk , Course , Information , People , Nhs , Approved , Research-team , Lydia-guthrie , Us , Process , Rachel-reeves

Breakfast-20201230-07:38:00

so we will start next week. and hospitals across the country are ready but we can also use this vaccine in primary care, we can take ita vaccine in primary care, we can take it a care homes, itjust needs normalfridge it a care homes, itjust needs normal fridge temperature rather than the super cold storage than the pfizer vaccine requires so we can get going on this from monday. have you got a target for the first week? i'm not putting numbers on it. it's very tempting but the reason is that the speed of the roll—out will be determined by how quickly this can be manufactured. the nhs will be able to deliver it at the speed of which it can be manufactured and approved for use. today we've got the approvalfor the approved for use. today we've got the approval for the vaccine as a whole. each batch needs to be individually approved to make sure that everything has gone right in the manufacture. so, as soon as the

Astrazeneca-coronavirus-vaccine , Country , Hospitals , Care , Ita-vaccine , Primary-care , Care-homes , Itjust , Vaccine , Numbers , Pfizer , Temperature

Breakfast-20201230-07:14:00

vaccines that are affordable, not for profit. and are easily deliverable. and that really is the most important thing. the effectiveness of the vaccine is really dependent on how many people's arms you can get it into. this technology allows that. can you just explain simply, if possible, in layman terms, how this actually works? well, as with all vaccines, what it does is it stimulates the body to produce an immune response. within this vaccine it stimulates two arms of the immune system, antibodies and t cells. these two arms of the immune system well for broader protection and stronger protection than if you just stimulate one or the other. it is really designed to produce higher levels. i think some of the unknown

Astrazeneca-coronavirus-vaccine , People , Thing , Vaccines , Effectiveness , Arms , Profit , Technology , Terms , Response , Immune-system , Body

Breakfast-20201230-07:41:00

we will therefore target the vaccine at those who need that protection is the most. and, also, at the nhs staff and social care workers who ca re staff and social care workers who care for all of us but in particular ca re care for all of us but in particular care for all of us but in particular care for the elderly and those who are most vulnerable to this disease. so, just hold on, you mentioned vulnerable people, care home staff, nhs staff, and i know from the pfizer list it went down to people over 50 so is that where you are aiming to orwill over 50 so is that where you are aiming to or will people other than ca re aiming to or will people other than care workers in care homes and a 50 get it? under 50s will get if they are clinically vulnerable to coronavirus and if they've received letters during the pandemic about shielding and the specific arrangements that are necessary for those clinically vulnerable. if you get those letters and then you are on the clinically vulnerable list, you will be moved forward, including

Astrazeneca-coronavirus-vaccine , Nhs , Care , Protection , Staff , Care , Workers , All-of-us , Social-care , Most , Who , People

Breakfast-20201230-07:39:00

material and vaccine can be prepared, and authorised, the nhs will then be able to deliver it. how many doses do you have ready right now? well, of this one, the number that will be ready for next week is in the hundreds of thousands, and, then, the numbers increased significantly after that. can you tell us about care homes? will this be going for example in that first week to care homes? yes. in the first instance, it'll be administered in hospitals, as the pfizer vaccine was. then we will be able to get out and vaccinate all the residents of care homes or offer the residents of care homes or offer the vaccination to residents of care homes and care home staff. we already started that programme with the pfizer vaccine and thousands of residents of care homes have already been vaccinated. but the need to

Astrazeneca-coronavirus-vaccine , Nhs , Number , Doses , Material , One , Numbers , Example , Care-homes , Hundreds-of-thousands , Vaccine , Hospitals